CETP inhibitors

Drug / Medication

A class of drugs with a history of failures initially, but with new promise for lowering LDL and impacting other diseases.

Mentioned in 2 videos

Videos Mentioning CETP inhibitors

255-Latest therapeutics in CVD, APOE’s role in Alzheimer’s disease, familial hypercholesterolemia

255-Latest therapeutics in CVD, APOE’s role in Alzheimer’s disease, familial hypercholesterolemia

Peter Attia MD

A class of drugs with a history of failures initially, but with new promise for lowering LDL and impacting other diseases.

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

Peter Attia MD

A class of drugs that raise HDL cholesterol, but trials (like Reveal) showed no or even negative outcomes, suggesting HDL cholesterol quantity is not the key metric.